Manuela Marron1, Lara Kim Brackmann1, Pia Kuhse1, Lara Christianson2, Ingo Langner3, Ulrike Haug3,4, Wolfgang Ahrens1,5. 1. Leibniz Institute for Prevention Research and Epidemiology-BIPS, Department Epidemiological Methods and Etiological Research, Bremen, Germany. 2. Leibniz Institute for Prevention Research and Epidemiology-BIPS, Library, Bremen, Germany. 3. Leibniz Institute for Prevention Research and Epidemiology-BIPS, Department Clinical Epidemiology, Bremen, Germany. 4. University of Bremen, Faculty of Human and Health Sciences, Bremen, Germany. 5. University of Bremen, Faculty of Mathematics and Computer Science, Bremen, Germany.
Abstract
INTRODUCTION: Infections may play a role in the etiology of childhood cancer and immunizations may be protective because vaccinations stimulate the immune system. Observational studies reported inconsistent associations between vaccination and risk of childhood cancer. Since a synthesis of the evidence is lacking, we conducted a meta-analysis stratified by histological and site-specific cancer. METHODS: We performed a systematic review (CRD42020148579) following PRISMA guidelines and searched for literature in MEDLINE, Embase, and the Science Citation Index databases. We identified in three literature databases 7,594 different articles of which 35 met the inclusion criteria allowing for 27 analyses of 11 cancer outcomes after exposure to nine different types of vaccinations. We calculated summary odds ratios (ORs) and 95% confidence intervals (CIs) using random effects models. RESULTS: We observed four inverse associations between childhood leukemia and certain vaccines as well as the number of vaccinations: OR 0.49 (95% CI = 0.32 to 0.74) for leukemia death after bacillus Calmette-Guérin vaccination; OR 0.76 (95% CI = 0.65 to 0.90) for acute lymphoblastic leukemia after Haemophilus influenzae type b vaccination; OR 0.57 (95% CI = 0.36 to 0.88) for leukemia; and OR 0.62 (95% CI = 0.46 to 0.85) for acute lymphoblastic leukemia after three or more vaccinations of any type. All other conducted analyses did not show any associations. DISCUSSION: The results are consistent with the hypothesis that vaccinations reduce the risk of childhood leukemia. However, the robustness and validity of these results is limited due to the small number, substantial heterogeneity, and methodological limitations of available studies.
INTRODUCTION: Infections may play a role in the etiology of childhood cancer and immunizations may be protective because vaccinations stimulate the immune system. Observational studies reported inconsistent associations between vaccination and risk of childhood cancer. Since a synthesis of the evidence is lacking, we conducted a meta-analysis stratified by histological and site-specific cancer. METHODS: We performed a systematic review (CRD42020148579) following PRISMA guidelines and searched for literature in MEDLINE, Embase, and the Science Citation Index databases. We identified in three literature databases 7,594 different articles of which 35 met the inclusion criteria allowing for 27 analyses of 11 cancer outcomes after exposure to nine different types of vaccinations. We calculated summary odds ratios (ORs) and 95% confidence intervals (CIs) using random effects models. RESULTS: We observed four inverse associations between childhood leukemia and certain vaccines as well as the number of vaccinations: OR 0.49 (95% CI = 0.32 to 0.74) for leukemia death after bacillus Calmette-Guérin vaccination; OR 0.76 (95% CI = 0.65 to 0.90) for acute lymphoblastic leukemia after Haemophilus influenzae type b vaccination; OR 0.57 (95% CI = 0.36 to 0.88) for leukemia; and OR 0.62 (95% CI = 0.46 to 0.85) for acute lymphoblastic leukemia after three or more vaccinations of any type. All other conducted analyses did not show any associations. DISCUSSION: The results are consistent with the hypothesis that vaccinations reduce the risk of childhood leukemia. However, the robustness and validity of these results is limited due to the small number, substantial heterogeneity, and methodological limitations of available studies.
Authors: J L Wiemels; G Cazzaniga; M Daniotti; O B Eden; G M Addison; G Masera; V Saha; A Biondi; M F Greaves Journal: Lancet Date: 1999-10-30 Impact factor: 79.321
Authors: Lisa R Treviño; Wenjian Yang; Deborah French; Stephen P Hunger; William L Carroll; Meenakshi Devidas; Cheryl Willman; Geoffrey Neale; James Downing; Susana C Raimondi; Ching-Hon Pui; William E Evans; Mary V Relling Journal: Nat Genet Date: 2009-08-16 Impact factor: 38.330
Authors: P A McKinney; R A Cartwright; J M Saiu; J R Mann; C A Stiller; G J Draper; A L Hartley; P A Hopton; J M Birch; J A Waterhouse Journal: Arch Dis Child Date: 1987-03 Impact factor: 3.791
Authors: Srividya Swaminathan; Lars Klemm; Eugene Park; Elli Papaemmanuil; Anthony Ford; Soo-Mi Kweon; Daniel Trageser; Brian Hasselfeld; Nadine Henke; Jana Mooster; Huimin Geng; Klaus Schwarz; Scott C Kogan; Rafael Casellas; David G Schatz; Michael R Lieber; Mel F Greaves; Markus Müschen Journal: Nat Immunol Date: 2015-05-18 Impact factor: 25.606
Authors: Mahrrouz Caputo; Heike Raupach-Rosin; André Karch; Michael Borte; Irina Lehmann; Uwe Gerd Liebert; Marie Standl; Joachim Heinrich; Rafael T Mikolajczyk Journal: Front Pediatr Date: 2019-06-25 Impact factor: 3.418